Skip Navigation
MUSC mobile menu


Support the Department of Medicine

Thank you for your interest in supporting the Department of Medicine at MUSC. Each day we strive to train the next generation of physicians, improve patient care and conduct groundbreaking research. But our work would not be possible without valued donors such as you. 

There are many philanthropic opportunities to support our mission, and each gift to the department makes an impact on our daily efforts. We hope that you will partner with us to advance education, expand research and improve excellence in patient care.

You may direct a gift to our Department of Medicine Research and Education fund, which benefits our most pressing needs in the department, or you may designate to a fund of your choice.

If you have any questions or would like to discuss your interest in making a gift to the Department of Medicine, please contact us.

Current Philanthropic Priorities

Donald O. Castell, M.D., Endowed Chair

The Department of Medicine and the Division of Gastroenterology & Hepatology are seeking to establish the Donald O. Castell, M.D., Endowed Chair.


J. Michael Kilby, M.D. Endowment

The J. Michael Kilby, M.D. Endowment was established in memory of Dr. Kilby with the long-term goal of creating an endowed chair, the most coveted and highly esteemed legacy possible at MUSC. Contributions given to this meaningful tribute campaign will support the Infectious Diseases Division and help establish a permanent fund in support of its educational, research and clinical programs.


Jay Brzezinski, M.D. Clinical Educator Professorship

An endowed professorship will allow MUSC the opportunity to recognize the contributions and achievements of Dr. Brzezinski while honoring his commitment to academic medicine by supporting a junior faculty member who has demonstrated excellence in teaching. This professorship would serve as a permanent reminder of Dr. Brzezinski’s commitment to scholarly and clinical excellence while furthering the educational mission of the university.


John A. Colwell, M.D. Ph.D. Endowed Chair

The John A. Colwell, M.D., Ph.D. Endowed Chair in Diabetes will ensure that the University’s diabetes program remains a national leader in diabetes research and patient care and will honor Dr. Colwell’s legacy in perpetuity.


Juanmanuel Gomez Educational Fund

The Division of Infectious Disease established the Juanmanuel Gomez Education Fund in March, 2014 in honor of Juanmanuel Gomez, M.D., MSCR, Assistant Professor. Dr. Gomez sadly passed away in October of 2014. Dr. Gomez was well known for his rigorous and enthusiastic bedside teaching. He was chosen by the department's fellows for the Teacher of the Year Award 2011-2012. He was much beloved by his patients for his high expectations for their self-care and because of his own tender thoughtful care. This important fund will help to support lectures and continuing medical education related to infectious diseases and international health.


Susan Pearlstine Sarcoidosis Center of Excellence

Susan Pearlstine established the Susan Pearlstine Sarcoidosis Center of Excellence through a generous donation to MUSC. While seeking treatment, she noted the immediate need for comprehensive services for herself and others. In the United States, almost 50 percent of patients require four or more physician visits before a diagnosis of sarcoidosis is made. With mortality rates from sarcoidosis increasing, and with South Carolina having the fourth highest sarcoidosis-related mortality in the United States, the critical need for comprehensive service provision was clear.


Upcoming Events


Check back soon!
  • Changing What's Possible

    South Carolina's only comprehensive academic medical center.

  • Susan Pearlstine Sarcoidosis Center of Excellence

    Susan Pearlstine Sarcoidosis Center of Excellence

    Susan Pearlstine established the Susan Pearlstine Sarcoidosis Center of Excellence as a nationally leading program to develop new treatments and therapies, and to build a clinical infrastructure that provides sarcoidosis patients with well-coordinated, patient-friendly access to the latest treatments available.